OPKO Health Inc
NASDAQ:OPK
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.8655
1.68
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one OPK stock under the Base Case scenario is 1.57 USD. Compared to the current market price of 1.52 USD, OPKO Health Inc is Undervalued by 3%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
OPKO Health Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for OPK cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
OPKO Health Inc
Balance Sheet Decomposition
OPKO Health Inc
Current Assets | 358m |
Cash & Short-Term Investments | 40.6m |
Receivables | 116m |
Other Current Assets | 201.4m |
Non-Current Assets | 1.6B |
Long-Term Investments | 101.5m |
PP&E | 128.4m |
Intangibles | 1.4B |
Other Non-Current Assets | 7.8m |
Current Liabilities | 219.6m |
Accounts Payable | 82.2m |
Accrued Liabilities | 98.6m |
Other Current Liabilities | 38.7m |
Non-Current Liabilities | 365m |
Long-Term Debt | 184.1m |
Other Non-Current Liabilities | 180.9m |
Earnings Waterfall
OPKO Health Inc
Revenue
|
716.4m
USD
|
Cost of Revenue
|
-530.2m
USD
|
Gross Profit
|
186.1m
USD
|
Operating Expenses
|
-452.7m
USD
|
Operating Income
|
-266.6m
USD
|
Other Expenses
|
23.5m
USD
|
Net Income
|
-243.1m
USD
|
Free Cash Flow Analysis
OPKO Health Inc
USD | |
Free Cash Flow | USD |
For Q2 2024, OPKO Health reported a net loss of $10.3 million, improved from a $19.6 million loss in 2023. Diagnostic segment revenue grew 2% year-over-year to $129.4 million, while expenses dropped 9%, reducing the operating loss by 40%. The Pharmaceutical segment saw a drop in revenue to $52.8 million mainly due to a $90 million milestone payment in the prior year. Looking forward, OPKO expects Q3 gross profit share payments from Pfizer between $7 million and $9 million, and $15 million to $20 million for the second half of 2024. The Labcorp transaction is set to close by early October, anticipated to significantly aid in returning to profitability.
What is Earnings Call?
OPK Profitability Score
Profitability Due Diligence
OPKO Health Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
Score
OPKO Health Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
OPK Solvency Score
Solvency Due Diligence
OPKO Health Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Score
OPKO Health Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OPK Price Targets Summary
OPKO Health Inc
According to Wall Street analysts, the average 1-year price target for OPK is 4.04 USD with a low forecast of 2.02 USD and a high forecast of 8.93 USD.
Dividends
Current shareholder yield for OPK is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
OPK Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. The company is headquartered in Miami, Florida and currently employs 5,767 full-time employees. The Company’s segments include Diagnostics and Pharmaceutical. The Diagnostics segment consists of the clinical laboratory operations of Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health) and GeneDx. Its Pharmaceutical Business have one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Oxyntomodulin, Biologics, Factor VIIa -CTP and hGH-CTP. The company also owns an active pharmaceutical ingredients (APIs) manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.
Officers
The intrinsic value of one OPK stock under the Base Case scenario is 1.57 USD.
Compared to the current market price of 1.52 USD, OPKO Health Inc is Undervalued by 3%.